The miR-SNP of rs11077 of XPO5 has been associated with the risk of esophageal cancer (OR = 1.84, 95% CI: 1.16–2.93, and p = 0.010) as well as the overall survival in myeloma and lymphoma [28, 55, 56]. Here, XPO5 is linked to plasma cell myeloma.